These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4034882)

  • 21. Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes.
    Giardina G; Clarke GD; Grugni M; Sbacchi M; Vecchietti V
    Farmaco; 1995 Jun; 50(6):405-18. PubMed ID: 7669179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of absolute configuration of a series of compounds with actions on dopamine receptors in the central nervous system.
    Wikström H; Sundell S; Lundmark M
    Acta Pharm Suec; 1985; 22(2):75-88. PubMed ID: 4050457
    [No Abstract]   [Full Text] [Related]  

  • 23. [Gangliosides of brain by stimulation of CNS].
    Epshteĭn IaA; Maksimova AM
    Biokhimiia; 1967 May; 32(3):504-9. PubMed ID: 4175788
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quantum chemical study of relation between drug effect and chemical structure. 1. Significance of the central effect of amphetamine derivatives].
    Nagy M; Nador K
    Arzneimittelforschung; 1967 Oct; 17(10):1228-31. PubMed ID: 5632862
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations, particularly by means of the anticholinesterase agents, of the multiple peripheral and central cholinergic mechanisms and of their behavioral implications.
    Karczmar AG; Ishi S; Blaber LC
    Acta Vitaminol Enzymol; 1970; 24(4):131-89. PubMed ID: 5537191
    [No Abstract]   [Full Text] [Related]  

  • 27. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug injuries and central nervous system (pathochemistry) (report) (author's transl)].
    Quadbeck G
    Verh Dtsch Ges Pathol; 1972; 56():106-11. PubMed ID: 4130813
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chemistry of 1,2,5-oxadiazole. (IV)(1). Synthesis and properties of alkyl N-(3-methylfurazan-4-yl) carbamates].
    Gasco A; Ruà G; Menziani E; Mortarini V; Fundarò A
    Farmaco Sci; 1971 Mar; 26(3):241-6. PubMed ID: 5550052
    [No Abstract]   [Full Text] [Related]  

  • 30. New treatment approaches in primary central nervous system lymphoma.
    Soussain C; Hoang-Xuan K; Doolittle ND
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):719-28, vii. PubMed ID: 16083832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemistry and CNS-effects of 2-aminomethyl-2'--hydroxybiphenyls and 2-aminomethyl-2' 3'-dihydroxybiphenyls.
    Misiorny A; Ross SB; Stjernström NE
    Acta Pharm Suec; 1977; 14(1):105-12. PubMed ID: 855666
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxic effects of drugs on the central nervous system].
    Poser S; Poser W
    Nervenarzt; 1983 Dec; 54(12):615-23. PubMed ID: 6664389
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monoamines and the pharmacological effects of tricyclic antidepressive agents].
    Garattini S; Bonaccorsi A; Jori A; Samanin R
    Rev Neurol (Paris); 1972 Aug; 127(2):265-92. PubMed ID: 4603688
    [No Abstract]   [Full Text] [Related]  

  • 34. [The teratogenic risk in the use of drugs].
    Gottschewski GH
    Wien Med Wochenschr; 1967 Oct; 117(42):937-44. PubMed ID: 5627407
    [No Abstract]   [Full Text] [Related]  

  • 35. [The blood-brain barrier is challenging drug development].
    Savolainen J; Mannila A
    Duodecim; 2005; 121(1):37-43. PubMed ID: 15712834
    [No Abstract]   [Full Text] [Related]  

  • 36. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is nose-to-brain transport of drugs in man a reality?
    Illum L
    J Pharm Pharmacol; 2004 Jan; 56(1):3-17. PubMed ID: 14979996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theories of the mechanism of action of inhalation anesthetics.
    Petty C
    Aeromed Rev; 1969 Apr; 2():1-35. PubMed ID: 4899350
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemical and pharmacological study of new derivatives of noradrenaline].
    Régnier G; Canevari R; Laubie M; Le Douarec JC
    Arzneimittelforschung; 1969 Oct; 19(10):1698-702. PubMed ID: 5395370
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical pharmacology of seduxen].
    Beliakov VA
    Anesteziol Reanimatol; 1980 Aug; (4):57-61. PubMed ID: 7416550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.